ACP
Acuta Capital Partners Portfolio holdings
AUM
$71.6M
This Quarter Return
+20.9%
1 Year Return
+169.78%
3 Year Return
+1,553.75%
5 Year Return
+4,509.01%
10 Year Return
+155,159.98%
AUM
$277M
AUM Growth
+$277M
(+10%)
Cap. Flow
-$11.5M
Cap. Flow
% of AUM
-4.15%
Top 10 Holdings %
Top 10 Hldgs %
64.04%
Holding
71
New
16
Increased
8
Reduced
11
Closed
11
Top Buys
| 1 |
Acadia Pharmaceuticals
ACAD
|
$9.38M |
| 2 |
VIVE
VIVEVE MED INC
VIVE
|
$7.22M |
| 3 |
BioCryst Pharmaceuticals
BCRX
|
$6.47M |
| 4 |
TSRO
TESARO, Inc.
TSRO
|
$5.39M |
| 5 |
ZGNX
Zogenix, Inc.
ZGNX
|
$4.74M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$27.2M |
| 2 |
Akebia Therapeutics
AKBA
|
$7.28M |
| 3 |
NDRM
NeuroDerm Ltd. Ordinary Shares
NDRM
|
$5.73M |
| 4 |
Aclaris Therapeutics
ACRS
|
$5.15M |
| 5 |
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
|
$4.47M |
Sector Composition
| 1 | Healthcare | 92.59% |
| 2 | Technology | 2.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Veracyte
VCYT
$2.39B
| $28.3M | 6.71% | 3,083,559 -429,602 | -12% | -$3.94M |
|
2
Assembly Biosciences
ASMB
$190M
| $28M | 6.65% | 1,100,000 +123,401 | +13% | +$3.15M |
|
3
Iovance Biotherapeutics
IOVA
$807M
| $25.4M | 6.03% | 3,415,044 -394,900 | -10% | -$2.94M |
|
4
IRIDEX
IRIX
$22.8M
| $20.1M | 4.76% | 1,691,865 +137,719 | +9% | +$1.63M |
|
|
5
Acadia Pharmaceuticals
ACAD
$4.38B
| $19.7M | 4.67% | 572,756 +272,756 | +91% | +$9.38M |
|
6
Ascendis Pharma
ASND
$11.8B
| $15.4M | 3.65% | 550,000 -25,309 | -4% | -$709K |
|
7
PDS Biotechnology
PDSB
$57.8M
| $12.3M | 2.92% | 1,351,516 +311,251 | +30% | +$2.84M |
|
|
NDRM
8
DELISTED
NeuroDerm Ltd. Ordinary Shares
NDRM
| $11.9M | 2.83% | 450,000 -215,944 | -32% | -$5.73M |
|
|
NBRV
9
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
| $8.13M | 1.93% | 677,710 -28,673 | -4% | -$344K |
|
|
10
BioCryst Pharmaceuticals
BCRX
$1.74B
| $7.73M | 1.83% | 920,310 +770,310 | +514% | +$6.47M |
|
|
VIVE
11
DELISTED
VIVEVE MED INC
VIVE
| $7.22M | 1.71% | +1,140,000 | New | +$7.22M |
|
|
CASM
12
DELISTED
CAS Medical Systems, Inc.
CASM
| $6.41M | 1.52% | 4,422,500 +242,662 | +6% | +$352K |
|
|
CEMI
13
DELISTED
Chembio diagnostics, Inc.
CEMI
| $6.37M | 1.51% | 1,202,144 +51,219 | +4% | +$271K |
|
|
OXFD
14
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $5.98M | 1.42% | 386,100 -84,734 | -18% | -$1.31M |
|
|
15
Aclaris Therapeutics
ACRS
$209M
| $5.96M | 1.41% | 200,000 -172,753 | -46% | -$5.15M |
|
|
TSRO
16
DELISTED
TESARO, Inc.
TSRO
| $5.39M | 1.28% | +35,000 | New | +$5.39M |
|
17
Marvell Technology
MRVL
$54.2B
| $5.34M | 1.27% | 350,000 -150,000 | -30% | -$2.29M |
|
|
RARX
18
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $5.28M | 1.25% | 247,956 -129,953 | -34% | -$2.77M |
|
|
DBVT
19
DBV Technologies
DBVT
$264M
| $5.27M | 1.25% | 149,690 +57,792 | +63% | +$2.04M |
|
|
ZGNX
20
DELISTED
Zogenix, Inc.
ZGNX
| $4.74M | 1.12% | +437,113 | New | +$4.74M |
|
|
VRAY
21
DELISTED
ViewRay, Inc.
VRAY
| $4.64M | 1.1% | +601,073 | New | +$4.64M |
|
|
AVXS
22
DELISTED
AveXis, Inc. Common Stock
AVXS
| $4.26M | 1.01% | +56,000 | New | +$4.26M |
|
23
AnaptysBio
ANAB
$569M
| $4.14M | 0.98% | +165,690 | New | +$4.14M |
|
|
MDCO
24
DELISTED
Medicines Co
MDCO
| $3.42M | 0.81% | +70,000 | New | +$3.42M |
|
25
Evolent Health
EVH
$1.12B
| $3.35M | 0.79% | +150,000 | New | +$3.35M |
|